Editorial: Cancer and nutrients: new chemicals, signals, and biomarker-based therapy

Xian-Yang Qin; Marco Antonio Mendoza-Parra; Yohei Shirakami

doi:10.3389/fonc.2023.1190065

Editorial: Cancer and nutrients: new chemicals, signals, and biomarker-based therapy

Front Oncol. 2023 Apr 11:13:1190065. doi: 10.3389/fonc.2023.1190065. eCollection 2023.

Authors

Xian-Yang Qin¹, Marco Antonio Mendoza-Parra², Yohei Shirakami³

Affiliations

¹ Laboratory for Cellular Function Conversion Technology, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.
² Génomique Métabolique, Genoscope, Institut François Jacob, CEA, CNRS, Université d'Évry, Université Paris-Saclay, Évry, France.
³ Department of Gastroenterology, Graduate School of Medicine, Gifu University, Gifu, Japan.

No abstract available

Keywords: cancer metabolism; cancer prognosis; chemoprevention; nutrition; precision medicine.

Publication types

Editorial

Grants and funding

This work was supported by Program for Basic and Clinical Research on Hepatitis from AMED under Grant Number JP22fk0210100h0001 (to X-YQ), by e-ASIA Joint Research Program from AMED under Grant Number 22jm0210092s0101 (to X-YQ), by Grant-in-Aid for Scientific Research (JP20K07349 to X-YQ) from the Japan Society for the Promotion of Science (JSPS), by RIKEN Incentive Research Project (to X-YQ), and by RIKEN IMS Center Director’s discretionary budget (to X-YQ).